tirzepatide cv outcomes trial The next wave of obesity/diabetes drugs is entering cardiovascular trials — and the mechanisms couldn't be more different 🧵 🔴 GLP1 agonism ( Tirzepatide) → ↓ MACE, HF, kidney outcomes ✓ established Gibco™ Human GLP-1 Recombinant Bundle:2 months supply tirzepatide hormone

tirzepatide cv outcomes trial The next wave of obesity/diabetes drugs is entering cardiovascular trials — and the mechanisms couldn't be more different 🧵 🔴 GLP1 agonism ( Tirzepatide) → ↓ MACE, HF, kidney outcomes ✓ established Gibco™ Human GLP-1 Recombinant Bundle:2 months supply tirzepatide hormone

Gibco™ Human GLP-1 Recombinant Protein, PeproTech®

GLP1 is produced by the L cells in the large and small intestines and are most dense in the ileum (the last part of the small intestine)

tirzepatide hormone

Bundle:2 months supply

Delay the speed of gastric emptying GLP-1 can also slow down the rate of gastric emptying, slowing down the digestion process of food in the stomach, thereby reducing the speed of glucose entering the bloodstream and helping to alleviate the rapid increase in postprandial blood sugar pressure